Table 2.
Clinical preventive services receipt among women, by disability status
Topic areas | Recommended clinical preventive services | Data sources | Service indicators | Prevalence of service receipt (%, standard error)
|
|
---|---|---|---|---|---|
Women with disabilities | Women without disabilities | ||||
Well visits | |||||
Physical examination | The Institute of Medicine recommends at least one well-women preventive care visit annually for adult women to obtain the recommended preventive services [11] | Behavioral Risk Factor Surveillance System (BRFSS), 2006–2010 | Women aged 18 years or older who received a routine checkup during the past year | 71.6 %, (0.4) [16] | 72.4 %, (0.2) [16] |
Vision examination | The American Optometric Association (AOA) recommends regular vision examinations for adults aged 18–60 years with no risk factors every 2 years; and adults at aged 60 years or older annually [12] | None identified | None identified | ||
Hearing examination | The American Speech–Language–Hearing Association (ASHA) recommends hearing screening for adults as needed, requested, or when they have conditions that place them at risk for hearing disability (e.g., family history, concern of family member); and for adults at least every decade through age 50 years and at 3-year intervals thereafter [13] | National Health and Nutrition Examination Survey (NHANES) Questionnaire, Sample Person (SP)—Audiometry, 2011–2012 | Women who had their hearing tested within the following time frames: <1 year, 1–4 years, 5–9 years, or 10+ years | Data exist but are not analyzed and published for women with disabilities | |
Preventive services | |||||
Teeth cleaning | The American Dental Association (ADA) recommends visiting your dentist regularly for professional cleanings and oral examinations [14] | BRFSS, 2010 | Women aged 18 years or older who received a teeth cleaning during the past year | 59.4 %, (1.0) [18] | 73.5 %, (0.2) [18] |
Influenza vaccination | The Advisory Committee on Immunization Practices (ACIP) recommends annual influenza vaccination for persons aged six months or older [15]. Note: In 1945, the Influenza trivalent vaccine became commercially available in the United States. In 2010, it included H1N1 | BRFSS, 2006–2010 | Women aged 18 years or older who received a seasonal flu shot during the past 12 months or the seasonal flu vaccine sprayed in the nose (FluMist™). | 39.1 %, (0.6) [16] | 35.1 %, (0.3) [16] |
Hepatitis A vaccination | The ACIP recommends a 2-dose HepA series for persons aged 12 months or older and those previously unvaccinated for whom immunity is desired [15]. Note: In 1995, the HepA vaccine became commercially available in the United States | NHIS, Sample Adult—Adult Access to Healthcare and Utilization, 2011 | Women who have ever received a HepA vaccine series—completed after the second shot is received | Data exist but are not analyzed and published for women with disabilities | |
Hepatitis B vaccination | The ACIP recommends a 3-dose HepB series for persons aged 6 months or older and those previously unvaccinated for whom immunity is desired [15]. Note: In 1982, the HepB vaccine became commercially available in the United States | BRFSS, 2007 | Women aged 18 years or older who have ever received a HepB vaccine series - completed after the third shot is received. | 36.7 %, (1.1) [18] | 39.4 %, (0.5) [18] |
Tetanus, diphtheria, pertussis vaccination | The ACIP recommends a single Tdap dose for adults aged 19–64 years [15]. Note: In 2005, the Tdap booster vaccine for adults became commercially available in the United States | NHIS, Sample Adult—Adult Access to Healthcare and Utilization, 2011 | Women who have ever received a pertussis or whooping cough vaccine (TdaP, ADACEL™ or BOOSTRIX™) | Data exist but are not analyzed and published for women with disabilities | |
Human papilloma virus (HPV) vaccination | The ACIP recommends routine vaccination of Women aged 11 or 12 years with 3 doses of either HPV2 or HPV4. The vaccination series can be started beginning at age 9 years. Vaccination is recommended for Women aged 13–26 years who have not been vaccinated previously or who have not completed the 3-dose series. If a female reaches age 26 years before the vaccination series is complete, remaining doses can be administered after age 26 years [15]. Note: In 2006, the HPV vaccine became commercially available in the United States |
|
|
Data exist but are not analyzed and published for women with disabilities | |
Zoster vaccination | ACIP recommends that zoster vaccination begin at age 60 years. The Zoster vaccine is Food and Drug Administration approved for administration as early as age 50 years [15]. Note: In 2006, Zoster vaccine became commercially available in the United States | NHIS, Sample Adult—Adult Access to Healthcare and Utilization, 2011 | Women who have ever received a Zoster or Shingles vaccine (Zostavax®) | Data exist but are not analyzed and published for women with disabilities. | |
Pneumococcal vaccination | The ACIP recommends pneumococcal vaccination of all persons aged 65 years and older; and 1–2 doses of pneumococcal vaccination before age 65 years if some other risk factor is present (e.g., on the basis of medical occupational, lifestyle, or other indications) [15]. Note: In 2000, the 7-valent Pneumococcal vaccine became commercially available in the United States. In 2010, the FDA licensed the 13-valent pneumococcal conjugate vaccine | BRFSS, 2006–2010 | Women aged 65 years or older who have ever received a pneumonia vaccine | 74.1 %, (0.4) [16] | 63.8 %, (0.4) [16] |
Aspirin therapy | The U.S. Preventive Services Task Force (USPSTF) recommends the use of aspirin for women aged 55–79 years when the potential benefit of a reduction in ischemic stroke outweighs the potential harm of an increase in gastrointestinal hemorrhage [10] |
|
|
Data exist but are not analyzed and published for women with disabilities | |
Screeening services | |||||
Cervical cancer screening | The USPSTF recommends Papanicolaou (Pap) screening every 3 years for women aged 21–65 years, every 5 years for women aged 30–65 years when screened with a combination of Pap and HPV testing [10] | BRFSS, 2010 | Women aged 18 years or older who received a Pap test during the past 3 years | 78.3 %, (0.8) [16] | 82.3 %, (0.4) [16] |
Lipid screening | The USPSTF recommends routine lipid disorder screening for women, aged 20–45 years if they have risk factors for coronary heart disease, and all women aged 45 years or older. The National Heart Lung and Blood Institute (NHLBI) recommends routine lipid screening for all adults aged 20 and older every 5 years [10] | BRFSS, 2009 | Women aged 20 years or older who received a blood test for cholesterol within the past 5 years | 82.1 %, (0.9) [18] | 79.3 %, (0.4) [18] |
Blood pressure screening | The USPSTF recommends routine blood pressure screening in all adults and treatment with anti-hypertensive medication to prevent incidence of cardiovascular disease [10] |
|
|
Data exist but are not analyzed and published for women with disabilities | |
Breast cancer screening | The USPSTF recommends mammography screening, with or without clinical breast examination, for women aged 40 years or older every 1–2 years [10] | BRFSS, 2010 | Women aged 40 years or older who received a mammogram during the past 2 years. | 70.7 %, (0.7) [16] | 76.6 %, (0.4) [16] |
Diabetes type 2 | The USPSTF recommends type 2 diabetes screening in asymptomatic adults with sustained blood pressure (either treated or untreated) greater than 135/80 mm Hg. The American Diabetes Association recommends type 2 diabetes screening for adults aged 45 years or older, especially those with a BMI ≥25 kg/m2 every 3 years with a fasting plasma glucose (FPG) measurement. The American Association of Clinical Endocrinologists recommends screening beginning at age 30 years for people at high risk for diabetes [10] | NHANES Questionnaire, Sample Person (SP)—Diabetes, 2011–2012 | Women who received a blood test for glucose or diabetes within the past 3 years | Data exist but are not analyzed and published for women with disabilities | |
Colon cancer screening | The USPSTF recommends colorectal cancer screening using fecal occult blood testing (FOBT), sigmoidoscopy, or colonoscopy for adults beginning at age 50 years and continuing until age 75 years. The risks and benefits of these screening methods vary [10] | BRFSS, 2010 | Women aged 50 years or older who received sigmoidoscopy or colonoscopy during the past 10 years or a fecal occult blood test (FOBT) during the past year, or both | 68 %, (0.6) [18] | 66.3 %, (0.5) [18] |
Osteoporosis screening | The USPSTF recommends routine Bone Mineral Density (BMD) screening beginning at age 60 years for women at increased risk for osteoporotic fractures; and routine screening for women aged 65 years or older [10]. The USPSTF does not mention screening periodicity | None identified | None identified | ||
Mental health screening | The USPSTF recommends screening adults for depression when supports are in place to assure accurate diagnosis, effective treatment and follow up [10] | None identified | None identified | ||
Screening & Counseling Services | |||||
Pregnancy planning screening and counseling | The IOM recommends educating and counseling all women with reproductive capacity about available FDA-approved methods of contraception and sterilization [11] | National Survey of Family Growth (NSFG), 2008 | Women aged 15–19 years who received formal education on birth control methods | 67 %, (CI not provided) [17] | 70 %, (CI not provided) [17] |
Tobacco screening and counseling | The USPSTF recommends screening all adults for tobacco use and providing tobacco cessation interventions for those who use tobacco products [10] | NHIS, Sample Adult—Adult Access to Healthcare and Utilization, 2011 | Women who received a routine physical examination within the last 3 years and whose provider asked about tobacco use | Data exist but are not analyzed and published for women with disabilities | |
Alcohol misuse screening and counseling | The USPSTF recommends screening and behavioral counseling interventions to reduce alcohol misuse by adults, including pregnant women, in primary care settings [10] | NHIS, Sample Adult—Adult Access to Healthcare and Utilization, 2011 | Women who received a routine physical examination within the last 3 years and whose provider asked about alcohol use | Data exist but are not analyzed and published for women with disabilities | |
Weight control screening and counseling | The USPSTF recommends screening for obesity among all adults and offering intensive counseling and behavioral interventions to promote sustained weight loss for obese adults [10]. The USPSTF also recommends intensive behavioral dietary counseling for adult patients with hyperlipidemia and other known risk factors for cardiovascular and diet-related chronic disease. Intensive counseling can be delivered by primary care clinicians or by referral to other specialists such as nutritionists or dietitians [10] |
MEPS—HC, Preventive Care (AP) section, 2011 | Women who have ever received advice from their doctor or other health professional to eat fewer high fat or high cholesterol foods or exercise more | Data exist but are not analyzed and published for women with disabilities | |
Human Immunodeficiency (HIV) Screening | The USPSTF recommends HIV screening for all adolescents and adults at increased risk for HIV infection [10] | BRFSS, 2006–2010 | Women aged 18–64 years who have ever received a test for HIV, including tests of fluid from the mouth, not including tests received as part of a blood donation | 51.1 %, (0.6) [16] | 42.5 %, (0.2) [16] |
Sexually transmitted infections (STI) and human immunodeficiency virus (HIV) counseling | The IOM recommends annual counseling on STIs and HIV for all sexually active women [11] | None identified | None identified | ||
Violence screening & counseling | The IOM recommends screening and counseling women and youth for interpersonal and domestic violence [11] | None identified | None identified | ||
Estrogen replacement therapy (ERT) counseling | The USPSTF recommends ERT benefit and risk counseling by a healthcare provider among all women aged 40 or older. This is also recommended for all peri-and postmenopausal women, or all postmenopausal women by the American College of Obstetrics, American College of Physicians, American Academy of Family Physicians, and American Geriatric Society [10] | NHIS, Sample Adult—Adult Access to Healthcare and Utilization, 2011 | Women with symptoms of menopause who have talked with a provider about estrogen replacement to prevent bone loss | Data exist but are not analyzed and published for women with disabilities |